Nicholas Zorko, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Caris Life Sciences
    Topic:
    Genetic testing
    Date added:
    06/15/2023
    Date updated:
    03/05/2024
    Relationship end date:
    01/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Telix Pharmaceuticals
    Topic:
    Radioligand Therapy/Nuclear Imaging
    Date added:
    06/15/2023
    Date updated:
    03/05/2024
    Relationship end date:
    01/01/2026
Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management